1. Home
  2. AEHR vs NRIX Comparison

AEHR vs NRIX Comparison

Compare AEHR & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEHR
  • NRIX
  • Stock Information
  • Founded
  • AEHR 1977
  • NRIX 2009
  • Country
  • AEHR United States
  • NRIX United States
  • Employees
  • AEHR N/A
  • NRIX N/A
  • Industry
  • AEHR Electrical Products
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEHR Industrials
  • NRIX Health Care
  • Exchange
  • AEHR Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • AEHR 864.2M
  • NRIX 750.4M
  • IPO Year
  • AEHR 1997
  • NRIX 2020
  • Fundamental
  • Price
  • AEHR $21.04
  • NRIX $13.08
  • Analyst Decision
  • AEHR
  • NRIX Strong Buy
  • Analyst Count
  • AEHR 0
  • NRIX 14
  • Target Price
  • AEHR N/A
  • NRIX $26.29
  • AVG Volume (30 Days)
  • AEHR 1.3M
  • NRIX 1.9M
  • Earning Date
  • AEHR 10-06-2025
  • NRIX 10-09-2025
  • Dividend Yield
  • AEHR N/A
  • NRIX N/A
  • EPS Growth
  • AEHR N/A
  • NRIX N/A
  • EPS
  • AEHR N/A
  • NRIX N/A
  • Revenue
  • AEHR $56,818,000.00
  • NRIX $83,687,000.00
  • Revenue This Year
  • AEHR $1.91
  • NRIX $58.48
  • Revenue Next Year
  • AEHR $36.69
  • NRIX N/A
  • P/E Ratio
  • AEHR N/A
  • NRIX N/A
  • Revenue Growth
  • AEHR N/A
  • NRIX 48.32
  • 52 Week Low
  • AEHR $6.27
  • NRIX $8.18
  • 52 Week High
  • AEHR $34.35
  • NRIX $28.13
  • Technical
  • Relative Strength Index (RSI)
  • AEHR 37.52
  • NRIX 63.09
  • Support Level
  • AEHR $22.66
  • NRIX $12.01
  • Resistance Level
  • AEHR $25.49
  • NRIX $13.03
  • Average True Range (ATR)
  • AEHR 1.78
  • NRIX 0.86
  • MACD
  • AEHR -0.41
  • NRIX -0.02
  • Stochastic Oscillator
  • AEHR 19.37
  • NRIX 88.47

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: